SEQ ID NO.01 of Patent CN 113234128A

General Information


DRACP ID  DRACP06005

Peptide Name   SEQ ID NO.01 of Patent CN 113234128A

Sequence  LLRHVVKILKYLHGVSGHGQHGVHG

Sequence Length  25

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C125H201N41O29

Absent amino acids  ACDEFMNPTW

Common amino acids  GH

Mass  317052

Pl  10.9

Basic residues  8

Acidic residues  0

Hydrophobic residues  9

Net charge  8

Boman Index  -1294

Hydrophobicity  2.4

Aliphatic Index  124.4

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  1490

Absorbance 280nm  62.08

Polar residues  7

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID CN113234128A

Patent Title  Anti-tumor active polypeptide and application thereof

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.